Amanda A van Vliet (Amanda van Vliet)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Tyrosine Kinase

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, Hans J van der Vliet, Jurriaan Tuynman, Jan Spanholtz, Tanja D de Gruijl
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (12) (2023)
Amanda A van Vliet, Anna-Maria Georgoudaki, Monica Raimo, Tanja D de Gruijl, Jan Spanholtz
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma. Cancers 13 (18) (2021)
Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, Lisa A King, Amanda A van Vliet, Bruce Walcheck, Henk M W Verheul, Jan Spanholtz, Jurriaan B Tuynman, Tanja D de Gruijl, Hans J van der Vliet
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor. Cancers 13 (21) (2021)